仁和药业：尚未了解有对标蚂蚁阿福的研发计划

Core Viewpoint - Renhe Pharmaceutical has not developed any plans to create AI+medical solutions that would compete with Ant Group's Aifufu, despite the growing interest in AI applications within the pharmaceutical industry [1] Group 1: Company Information - Renhe Pharmaceutical's founder, Yang Wenlong, is recognized as the wealthiest individual in Zhangshu, Jiangxi, and serves as the president of the China Over-the-Counter Drug Association [1] - The company manages numerous well-known traditional Chinese medicine and Western medicine enterprises, and operates the Dingdang Kuaibao app service [1] Group 2: Industry Context - The AI+medical sector is currently viewed as a cutting-edge area of development within the pharmaceutical industry, with Ant Group's Aifufu leading the market with approximately 30 million daily active users [1]